4//SEC Filing
McAvoy David R. 4
Accession 0001628280-23-033914
CIK 0000819050other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 9:40 PM ET
Size
10.2 KB
Accession
0001628280-23-033914
Insider Transaction Report
Form 4
McAvoy David R.
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2023-10-02+20,000→ 23,419 total - Tax Payment
Common Stock
2023-10-02$0.98/sh−7,358$7,209→ 16,061 total - Exercise/Conversion
Restricted Stock Units
2023-10-02−20,000→ 0 total→ Common Stock (20,000 underlying)
Holdings
- 310(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]The restricted stock units were granted on January 24, 2023 and were subject to accelerated vesting as of the date of the reporting person's termination pursuant to his employment agreement with the issuer.
- [F2]Each restricted stock unit converted into common stock on a one-for-one basis.
- [F3]This balance includes 555 shares purchased under the Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan that were not previously reported.
- [F4]On July 5, 2022, the registrant effected a 1-for-45 reverse stock split ("Reverse Stock Split") of its common stock. The number of shares beneficially owned has been adjusted to give effect to the Reverse Stock Split.
- [F5]Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
- [F6]The restricted stock units vested in full on October 2, 2023.
Documents
Issuer
Fresh Tracks Therapeutics, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001758842
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 9:40 PM ET
- Size
- 10.2 KB